BIAFW vs LNC · rev $6.2M vs P/E 4.9, rev $9.85B
bioAffinity Technologies Inc. Warrant (BIAFW) versus Lincoln National Corporation (LNC) — a side-by-side from cached financials, not a winner call.
bioAffinity Technologies Inc. Warrant (BIAFW) common stock listed on US.
Lincoln National Corporation (LNC) is a insurance - life company listed on US.
Latest reported BIAFW revenue for 2025-12-31 was $6.2M. Net income was -$14.9M. Revenue was down 34.2% from 2024-12-31 to 2025-12-31. BIAFW currently screens at market cap $0.
Latest reported LNC revenue for 2026-06-30 was $9.85B. Net income was $1.16B. Revenue was up 85.6% from 2026-03-31 to 2026-06-30. LNC currently screens at market cap $5.94B and trailing P/E 4.9.
BIAFW currently screens at market cap $0. LNC currently screens at market cap $5.94B and trailing P/E 4.9.
Not investment advice. Open the BIAFW and LNC stock pages for the full models.
Not investment advice.